Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page
Users Online: 42

Year : 2015  |  Volume : 12  |  Issue : 2  |  Page : 74-76

Savior turning into destroyer: An interesting case of destructive thyroiditis

1 Department of Neurology, Command Hospital, Chandimandir, Panchkula, Haryana, India
2 Department of Endocrinology, Command Hospital, Chandimandir, Panchkula, Haryana, India

Correspondence Address:
K V S Hari Kumar
Department of Endocrinology, Command Hospital, Chandimandir, Panchkula 134 107, Haryana
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0973-0354.153348

Rights and Permissions

Rituximab is a monoclonal antibody directed specifically against the CD20 resulting in depletion of B lymphocytes. Rituximab is used in multiple autoimmune disorders across the medical specialties including multiple sclerosis, myesthenia grevis, rheumatoid arthritis and inflammatory bowel disease. In the field of endocrinology, rituximab is indicated specifically in resistant cases of Graves' opthalmopathy. We recently encountered a patient of multiple sclerosis, developing features of destructive thyroiditis after a course of rituximab and report the same here.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded243    
    Comments [Add]    
    Cited by others 1    

Recommend this journal